< Back to previous page

Publication

Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Journal Contribution - Journal Article Conference Contribution

Journal: Annals Of Oncology

ISSN: 0923-7534

Volume: 32

Pages: S1449 - S1450

Publication year:2021

DOI: https://doi.org/10.1016/j.annonc.2021.10.178
Institutional Repository URL: https://lirias.kuleuven.be/3662749